Studies have shown that indicators such as brain natriuretic peptide (BNP), atrial morphology, spontaneous echo contrast (SEC), and coronary artery calcium score (CACS) may further assist decision on anticoagulant therapy for patients with AF to prevent stroke (7, 8). This evidence concerns the gene NPPB and stroke disorder.